ReviewHuman mutation2024

Treatability of the KMT2-Associated Neurodevelopmental Disorders Using Antisense Oligonucleotide-Based Treatments.

Bianca Zardetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.